1. Yin, Sha, Liao, Qinyuan, Wang, Yida, Yi, Ming, Huang, Jing. 2021. Ccdc134 deficiency impairs cerebellar development and motor coordination. In Genes, brain, and behavior, 20, e12763. doi:10.1111/gbb.12763. https://pubmed.ncbi.nlm.nih.gov/34382738/
2. Yu, Biaoyi, Zhang, Tianzhuo, Xia, Peng, Qiu, Xiaoyan, Huang, Jing. 2017. CCDC134 serves a crucial role in embryonic development. In International journal of molecular medicine, 41, 381-390. doi:10.3892/ijmm.2017.3196. https://pubmed.ncbi.nlm.nih.gov/29115376/
3. Huang, Zhijian, Yang, Linhui, Chen, Jian, Wang, Hongyan, Yu, Hui. 2022. CCDC134 as a Prognostic-Related Biomarker in Breast Cancer Correlating With Immune Infiltrates. In Frontiers in oncology, 12, 858487. doi:10.3389/fonc.2022.858487. https://pubmed.ncbi.nlm.nih.gov/35311121/
4. Dubail, Johanne, Brunelle, Perrine, Baujat, Geneviève, Koumakis, Eugénie, Cormier-Daire, Valérie. 2020. Homozygous Loss-of-Function Mutations in CCDC134 Are Responsible for a Severe Form of Osteogenesis Imperfecta. In Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 35, 1470-1480. doi:10.1002/jbmr.4011. https://pubmed.ncbi.nlm.nih.gov/32181939/
5. Ning, Haiping, Liang, Cuili, Mei, Huifen, Tan, Dongdong, Tan, Jianqiang. 2024. A Novel Homozygous Synonymous Variant in CCDC134 as a Cause of Osteogenesis Imperfecta Type XXII. In Clinical genetics, , . doi:10.1111/cge.14664. https://pubmed.ncbi.nlm.nih.gov/39623602/
6. Zhong, Jialing, Zhao, Mei, Luo, Qing, Sang, Jianli, Huang, Changzhi. 2012. CCDC134 is down-regulated in gastric cancer and its silencing promotes cell migration and invasion of GES-1 and AGS cells via the MAPK pathway. In Molecular and cellular biochemistry, 372, 1-8. doi:10.1007/s11010-012-1418-4. https://pubmed.ncbi.nlm.nih.gov/23070808/
智鼠故事 
